Alkem Laboratories gains on the BSE

03 Sep 2019

Alkem Laboratories is currently trading at Rs. 1819.00, up by 2.15 points or 0.12% from its previous closing of Rs. 1816.85 on the BSE.

The scrip opened at Rs. 1820.25 and has touched a high and low of Rs. 1827.15 and Rs. 1812.00 respectively. So far 223 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2265.00 on 10-Sep-2018 and a 52 week low of Rs. 1660.35 on 28-Jun-2019.

Last one week high and low of the scrip stood at Rs. 1840.00 and Rs. 1711.55 respectively. The current market cap of the company is Rs. 21787.73 crore.

The promoters holding in the company stood at 66.03%, while Institutions and Non-Institutions held 8.69% and 25.28% respectively.

The US Food and Drug Administration (USFDA) has completed inspection at Alkem Laboratories’ manufacturing facility located at Daman. The agency had conducted inspection from August 26, 2019 to August 30, 2019. At the end of the inspection, the company has received a Form 483 with two observations.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Related Alkem Laboratories Ltd. Links:

Alkem Laboratories Share Price

2025.70 0.00 (0.00%) Nov 14, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 410.05
Lupin 738.25
Dr. Reddys Lab 2734.00
Piramal Enterprises 1758.75
Cadila Healthcare 234.20
View more..
Sensex vs Alkem Laboratories
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463